Lizaso A - Search Results

1

Efficacy of Joungal in preventing febrile neutropenia induced by platinum-based doublet chemotherapy in lung cancer.

Zeng F, Li T, Xia C, Chen G, Sun Z, Guan R, Lizaso A, Mao X, Li K, Zhang Y. Zeng F, et al. Among authors: lizaso a. Ann Palliat Med. 2020 Jul;9(4):1688-1695. doi: 10.21037/apm-19-531. Epub 2020 Jun 23. Ann Palliat Med. 2020. PMID: 32648449 Free article.

2

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients.

Li M, Zhou CZ, Yang JJ, Lu S, Zheng D, Hu J, Zeng H, Lu Y, Lu KH, Li SA, Mao XR, Han-Zhang H, Lizaso A, Ye JY, Hu CP. Li M, et al. Among authors: lizaso a. Cancer Biol Ther. 2019;20(8):1097-1104. doi: 10.1080/15384047.2019.1595280. Epub 2019 Apr 16. Cancer Biol Ther. 2019. PMID: 30990107 Free PMC article.

3

Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.

Hu X, Yang D, Li Y, Li L, Wang Y, Chen P, Xu S, Pu X, Zhu W, Deng P, Ye J, Zhang H, Lizaso A, Liu H, Mao X, Huang H, Chu Q, Hu C. Hu X, et al. Among authors: lizaso a. Cancer Biol Med. 2019 Aug;16(3):556-564. doi: 10.20892/j.issn.2095-3941.2018.0506. Cancer Biol Med. 2019. PMID: 31565484 Free PMC article.

4

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients.

Ding Y, Zhang L, Guo L, Wu C, Zhou J, Zhou Y, Ma J, Li X, Ji P, Wang M, Zhu W, Shi C, Li S, Wu W, Zhu W, Xiao D, Fu C, He Q, Sun R, Mao X, Lizaso A, Li B, Han-Zhang H, Zhang Z. Ding Y, et al. Among authors: lizaso a. Thorac Cancer. 2020 Jan;11(1):103-112. doi: 10.1111/1759-7714.13208. Epub 2019 Nov 6. Thorac Cancer. 2020. PMID: 31692283 Free PMC article.

5

Detection of Nonreciprocal/Reciprocal ALK Translocation as Poor Predictive Marker in Patients With First-Line Crizotinib-Treated ALK-Rearranged NSCLC.

Zhang Y, Zeng L, Zhou C, Li Y, Wu L, Xia C, Jiang W, Hu Y, Liao D, Xiao L, Liu L, Yang H, Xiong Y, Guan R, Lizaso A, Mansfield AS, Yang N. Zhang Y, et al. Among authors: lizaso a. J Thorac Oncol. 2020 Jun;15(6):1027-1036. doi: 10.1016/j.jtho.2020.02.007. Epub 2020 Feb 27. J Thorac Oncol. 2020. PMID: 32112982 Free article.

6

Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case report.

Liu L, Lizaso A, Mao X, Yang N, Zhang Y. Liu L, et al. Among authors: lizaso a. Transl Lung Cancer Res. 2020 Feb;9(1):144-147. doi: 10.21037/tlcr.2020.01.10. Transl Lung Cancer Res. 2020. PMID: 32206561 Free PMC article.

7

A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab.

Zhou Y, Jiang W, Zeng L, Mi J, Song L, Lizaso A, Mao X, Yang N, Zhang Y. Zhou Y, et al. Among authors: lizaso a. Lung Cancer. 2020 May;143:55-59. doi: 10.1016/j.lungcan.2020.03.019. Epub 2020 Mar 19. Lung Cancer. 2020. PMID: 32208297

8

Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy.

Wang Y, Yang N, Zhang Y, Li Li, Han R, Zhu M, Feng M, Chen H, Lizaso A, Qin T, Liu X, He Y. Wang Y, et al. Among authors: lizaso a. J Thorac Oncol. 2020 Aug;15(8):1369-1375. doi: 10.1016/j.jtho.2020.04.014. Epub 2020 Apr 27. J Thorac Oncol. 2020. PMID: 32353596 Free article.

9

The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy.

Wang Y, Tian P, Xia L, Li L, Han R, Zhu M, Lizaso A, Qin T, Li M, Yu B, Mao X, Han-Zhang H, He Y. Wang Y, et al. Among authors: lizaso a. Lung Cancer. 2020 Aug;146:165-173. doi: 10.1016/j.lungcan.2020.06.003. Epub 2020 Jun 6. Lung Cancer. 2020. PMID: 32540560 Free article.

10

Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.

Hu X, Yang D, Li Y, Li L, Wang Y, Chen P, Xu S, Pu X, Zhu W, Deng P, Ye J, Zhang H, Lizaso A, Liu H, Mao X, Huang H, Chu Q, Hu C. Hu X, et al. Among authors: lizaso a. Cancer Biol Med. 2020 May 15;17(2):513. doi: 10.20892/j.issn.2095-3941.2020.0029. Cancer Biol Med. 2020. PMID: 32587786 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters